The midterm outcome and MACE of robotically enhanced grafting of left anterior descending artery with left internal mammary artery by Roberto Casula et al.
Casula et al. Journal of Cardiothoracic Surgery 2014, 9:19
http://www.cardiothoracicsurgery.org/content/9/1/19RESEARCH ARTICLE Open AccessThe midterm outcome and MACE of robotically
enhanced grafting of left anterior descending
artery with left internal mammary artery
Roberto Casula1, Espeed Khoshbin2* and Thanos Athanasiou3Abstract
Background: We assessed the midterm outcome and the incidence of major adverse cardiovascular events in UK’s
largest Da Vinci assisted robotic coronary revascularisation cohort. This study was set up at the Imperial College
NHS Trust, St. Mary’s Hospital, London, United Kingdom.
Method: Benchmarking approach through retrospective audit of the regional outcomes against standards in the
published literature. Data was collected from the patient’s records, communication with the primary care physicians
and the national strategic tracing service. The results were compared with the published literature. Patients who
underwent robotic assisted coronary revascularisation were included. Other robotic procedures or minimally
invasive revascularisation without the use of the Da Vinci robot were excluded. The main outcome measure was the
midterm survival up to five years and the incidence of major adverse cardiovascular events (MACE) up to three years.
Results: Since April 2002, one hundred consecutive patients underwent either off pump robotic assisted single vessel
small thoracotomy (SVST, n = 88), or off pump total endoscopic coronary artery bypass grafting (TCAB, n = 12). All
patients were operated on by the same primary surgeon but different assisting surgeons. All patients received a left
internal mammary arterial (LIMA) graft as planned. The primary outcome of total one month and three years MACE and
up to five year survival was 0, 9 and 96% respectively.
Conclusions: The procedural success rates in terms of morbidity and mortality up to five years are compatible to the
outcomes observed outside the United Kingdom. These results are not inferior to that of conventional off pump single
vessel coronary surgery or percutaneous coronary intervention to the LAD.
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In 1988, a robot developed at The Imperial College,
London was used to perform prostate surgery. This was
one of the first prototypes of its kind. The first reported
case of closed chest coronary surgery using the Da Vinci
robot (Intuitive Surgical, USA) took place at the turn of
the century by Utz Kappert [1]. Since our first reports of
successful attempts at robotically assisted coronary
revascularisation back at imperial college [2,3], over one
hundred coronary procedures have been successfully
performed using the same second generation Da Vinci* Correspondence: khoshbinuk@yahoo.co.uk
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reproduction in any medium, provided the orrobot (Figure 1). In 2010 we published the results of a
feasibility study and our short term outcomes in the
same group of patients [4]. In the current study in ac-
cordance to the definition, and the principles of best
practice in clinical audit [5,6], we compared our mid-
term outcomes of mortality and major adverse cardio-
vascular events (MACE) against international literature.Methods
This is an Institutional audit. We investigated our midterm
outcomes in terms of MACE up to three years and mortal-
ity for up to five years for single vessel small thoractomy
(SVST) and total endoscopic coronary bypass grafting
(TECAB). Permission was granted by the Imperial Collage
Healthcare Trust audit committee and information wasLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The standard second generation Da Vinci robot with
three robotic arms. The middle arm commonly used for the camera.
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cation with their primary care physician and the National
Strategic Tracing Service. Patients had undergone either
SVST or TECAB. All other robotic or other non robotic
minimal invasive coronary revascularisations such as MID-
CAB (Minimal invasive direct coronary artery bypass) were
excluded. The primary end points were the midterm up to
five years survival and major adverse cardiovascular event
such as death, myocardial infarction (MI), stroke and the
need for target vessel revascularisation (TVR). The secondary
end points were conversion rates to MIDCAB, re-operationFigure 2 SVST/TECAB surgical sequence. a) The port access position in th
the robotic arms from the console. c) The Left internal mammary artery is har
expose the targeted left anterior descending artery. Then the coronary anasto
f) totally endoscopically (TECAB).for bleeding, the incidence of atrial fibrillation, respiratory
complications and the median length of stay in hospital.
All patients signed an informed consent form prior to
their operative procedure and were fully aware of their
surgical approach options. All procedures were per-
formed by the same principal surgeon. A second gener-
ation standard da Vinci robot was used in all cases. The
robotic arms gained access into the left thoracic cavity
through three ports. First the left internal mammary ar-
tery (LIMA) was harvested and the left anterior descend-
ing artery (LAD) exposed through a pericardotomy. The
LIMA to LAD anastomosis was performed either
through a small anterior thoracotomy in SVST or it was
performed totally endoscopically using the robotic arms
in TECAB (Figure 2a-f ).
Results
One hundred patients fitted our criteria (SVST, n = 88 &
TECAB, n = 12). Table 1a summarises the patient char-
acteristics. There were striking features such as male
predominance and a raised body mass index (BMI). Pa-
tients were otherwise not discriminated on the basis of
being diabetic, having carotid disease or poor left ven-
tricular function. One in ten patients had three vessel
coronary artery disease and one in five had their robotic
procedure as part of a hybrid strategy which consisted of
an additional percutaneous coronary intervention (PCI).
The majority of patients had type B or C lesion character-
istics which according to the American Heart Associatione third, fifth and seventh interspaces. b) The operating surgeon controls
vested using the Da Vinci robot. d) Pericardotomy is performed to
mosis is performed either e) through a small left thoracotomy (SVST) or
Table 1 Summary of patient characteristics and outcomes
a) Preoperative characteristics b) Primary outcome measures
Number of patients in total 100 Peri-operative MACE (%) 0
Age 62 ± 11 Survival to discharge (%) 100
Male 95 30 Day MACE (%) 0
BMI Kg/m2 27.0 ± 3.3 Three year MACE (%) 9
Diabetes (%) 17 Three year Incidence of Death (%) 3
Mean creatinine 100 ± 22 Three year Incidence of MI (%) 2
Carotid disease (%) 10 Three year Incidence of Stroke (%) 1
Previous MI (%) 18 Three year Incidence of TVR (%) 3
Poor LV (%) 1 Five year incidence of death (%) 4
Previous PCI (%) 13
Hybrid strategy (%) 19 c) Secondary outcome measures
Redo (%) 1 Conversion rate to MIDCAB (%) 3
EUROScore 1.73 ± 1.93 Re-operation for bleeding (%) 0
NYHA (III&IV) (%) 18 Atrial fibrillation (%) 2
CCS (III&IV) (%) 18 Respiratory complications (%) 4
Lesion charachteristic Median length of stay (days) 4 ± 1
Type A (%) 10
Type B (%) 55
Type C (%) 35
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risk, with moderate to low chance of a successful PCI.
There were no major peri-operative cardiovascular
events. There were no conversions to median sternot-
omy or a need for cardiopulmonary bypass. All patients
survived to discharge. The primary outcome defined as
the total MACE was 0% at one and twelve months and
9% after three years. The five year mortality excluding
the patients operated less than 5 years from this analysis
was 4% (n = 85). Table 1b illustrates the 3 year MACE
split into its components of death 3%, myocardial infarc-
tion 2%, stroke 1% and target vessel revascularisation
(TVR) in 3%. A number of secondary outcome measures
were also observed (Table 1c), such as the conversion
rate to MIDCAB 3%, incidence of atrial fibrillation (AF)
2%, respiratory complications such as post operative left
sided pleural effusion in 4% and a median length of stay
in hospital of 4 ± 1 days.
Discussion
This is an audit into the primary and secondary out-
comes following robotic assisted single vessel coronary
surgery including short and medium term mortality, the
incidence of major adverse cardiovascular complications
and five year survival. The subjects formed the largest
cohort of patients in the United Kingdom who had their
coronary revascularisation enhanced using the Da Vinci
robot.The major limitation of this study is that there was no
compatible local control group to compare this cohort
against. The majority of patients who presented with a
single vessel LAD disease were considered and accepted
for robotic assisted surgery. A small number of female
patients with upper body obesity (large breasts) or pa-
tients with chest wall deformities were not considered as
candidates for this procedure. They were treated by the
conventional off pump method; however their number
was too small to be used as a control.
This audit was also limited due to its retrospective ob-
servational nature and that it lacks long term results. A
prospective or a propensity matched analysis would im-
prove the strength of these conclusions. However in this
cohort neither was possible. This study started over half
way through the patient recruitment process and the
population was grossly skewed with the male gender be-
ing over selected for the reasons already mentioned such
as the upper body obesity and chest deformity. With re-
spect to long term outcomes, this cohort is still under
observation and will be re audited with respect to their
long term outcomes.
In addition there were a number of procedure specific
limitations to the use of robotic enhanced coronary
grafting. One of the major limitations was the lack of
fourth arm on our early generation robot. This made it
technically challenging to perform the total endoscopic
procedures as well as extending the target anastomosis
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form our totally endoscopic cases in this part of our ex-
perience we used an externally operated mechanical
suction stabiliser inserted via a 4th thoraco-port. The
latest generation of Da Vinci robot with a fourth arm al-
lows the use of a suction stabiliser which is console-
driven instead. In addition bulkiness of the instruments
also made this approach unsuitable for smaller patients
or ones with chest wall deformities. This in a number of
cases resulted in leverage for example against a protrud-
ing shoulder. These problems may be resolved by devel-
opment and innovation of bioinspired and flexible
robotic systems such as the i-Snake® bimanual robot
(Hamlyn Centre, Imperial Collage, London).
We used a benchmarking approach to report our na-
tional experience be it from a single centre. As there are
no national standards for this type of surgery, we have
used the available worldwide literature as the standard
against which we conducted our audit.
Our results indicate that the primary outcomes matched
that of the literature for conventional single vessel off
pump coronary artery bypass (OPCAB) to the LAD in
terms of short and medium term survival. These have
been illustrated in Table 2. The reported thirty days and
12 month mortalities according to Herz et al. were 1% and
re intervention rates were 2% with conventional off pump
LIMA to LAD single graft anastomoisis as compared to
our 0% thirty days and twelve months mortality and 3% at
3 years [8]. Halkos et al. compared sternotomy versus
non-sternotomy LIMA to LAD grafting using either min-
imally invasive or robotic assisted harvesting of the LIMA,
followed by direct anastomosis to the LAD through a
small anterolateral thoracotomy. All 597 patients had sin-
gle vessel coronary disease. In their propensity adjusted
comparison, sternal sparing incisions were associated with
insignificant differences in 30 day adverse events such as
mortality 1.1% versus 0.9%, myocardial infarction 1.4%
versus 0.4% and 2.2 versus 2.6% for total MACE. Whereas
the incidence of stroke was higher in sternotomy group
0% versus 1.3% for non-sternotomy versus sternotomy re-
spectively (p = 0.03) [9]. Our incidence of Stroke was only
1% at three years. Kapper et al. Reported their five year
follow-up of robotic endoscopic coronary artery bypass.
They reported on 41 patients with proximal LAD disease
who had TECAB. 33 of these patients had the procedure
on a beating heart and of that 30 patients had single
LIMA to LAD anastomosis using the Da Vinci robot. The
rest (n = 11) had either on pump or multi vessel bypass.
Their overall five year survival was 92.7% however their
freedom from major cardiovascular event at five years was
75.6% [10]. The combined experience described by Bonatti
et al. of 498 patients who had on-pump single and multi
vessel TECAB showed a five year survival of 95.0% [11].
Their experience with on-pump single vessel TECAB in334 patients revealed a five year survival of 95.8% and a
freedom from MACE at five years of 73.5% [12]. All of
our twelve off-pump TECAB patients are alive over five
years from their surgery. However it is not possible to
make a fair comparison between our outcomes in this cat-
egory (TECAB) compared to the experience of Bonatti or
Kapper.
The long term results of endoscopically harvested LIMA
followed by atraumatic coronary artery bypass (endo-
ACAB) of LIMA to LAD was reported by Vassilades et al.
In a retrospective study he reviewed 607 consecutive pa-
tients that underwent endo-ACAB over eight years [13].
They reported a 30 day mortality of 1% and an overall
angiographic patency of over 95% for all lesion character-
istics. At five years they showed an event free survival of
92% (See Table 2 for breakdown of MACE). The event free
survival for our cohort at three years was 91%.
Our secondary outcomes were better than reported out-
comes in a similar cohort [14]. In a robotically-assisted off
pump coronary revascularisation study through a small
anterior thoracotomy, Turner et al. reported a 2.8% inci-
dence of reoperation for bleeding, atrial fibrillation (AF)
occurred in 8.5% of patients and the average length of stay
in hospital was 5.7 days compared to our report of 0%, 2%
and 4 days respectively. They also reported a similar 0%
operative mortality.
In a meta-analysis of the randomized trials [15]
Kapoor et al. concluded that in patients with single ves-
sel proximal LAD disease, who were eligible for both
procedures there was no difference in survival at any key
time points between PCI and CABG (99% for both by 30
days, 97.9% at one and 92.8% at five years with CABG
versus 99.7% at one and 90.6% at five years for PCI), nor
were there any difference in the rate of stroke or myo-
cardial infarction, but a significantly lower incidence of
repeated revascularisation in the CABG group (4% ver-
sus 19.5% at one year).
Obesity is not an independent risk factor for poor out-
come in minimally invasive cardiac surgery [16]. Being
overweight did not necessarily make this operation more
difficult [4]. However as the robotic arms are relatively
cumbersome the shape of the patient becomes a limiting
factor. For example Small female patients with relatively
large breasts were excluded on the basis of their size and
to avoid placing the robotic arms through the female
breast tissue. Patients with a deformed chest were also
considered carefully. The majority of the subjects in this
audit were essentially overweight men.
All the patients in this cohort received an arterial
(LIMA) graft. This is 100% arterial revascularisation
compared to 85% of patients who were destined for a
single vessel CABG through a standard median sternot-
omy according to the sixth national adult cardiac surgery
database.
Table 2 Comparison of composite outcomes in the published literature












Herz et al. Conventional OPCAB using LIMA 386 2.8% Bleeding 1% Mortality
8.5% AF
6 days MLOHS 2% TVR
Vassiliades et al. Endo-ACAB using LIMA 607 1% Mortality 1.6% Bleeding 2% Mortality 92%
1.6% MI 19.6% AF 2.1% MI
0.3% Stroke 11 days MLOHS 0.8% Stroke





Kappert et al. TECAB 41 92.7%





19.5 vs. 4% TVR
Bonatti et al. TECAB 334 0.3% Mortality 95.8%
Halkos et al. Sternotomy vs. Minimal invasive
Non-sternotomy using LIMA
234 vs. 363 1.1 vs. 0.9%
Mortality
1.4 vs. 0.4% MI
0 vs. 1.3% Stroke
2.2 vs. 2.6% MACE
Casula et al. Robotic enhanced using LIMA 100 0% Mortality 0% Bleeding 0% Mortality 0% Mortality 3% Mortality 96%
2% AF
0% MI 4 days 0% MI 2%
0% Stroke MLOHS 0% Stroke MI
3.0% 0% TVR 1% Stroke




MACE Major adverse cardiovascular events, MLOHS Mean length of hospital stay, TVR Target vessel revascularisation, AF Atrial fibrillation, MI Myocardial Infarction, LIMA Left internal mammary artery, OPCAB Off pump
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of the robot to improve post operative pain, general
health and physical function scores as compared to con-
ventional sternotomy [11], these conclusions have been
drawn from observational studies. We reported our an-
ecdotal evidence in favour of robotic enhancement
through earlier return to activities of daily living in our
last publication [4]. However there have been no rando-
mised trials in this subject.
Conclusion
These results show compatible national outcomes for
robotically enhanced coronary surgery in terms of mid-
term MACE and up to five years survival in the United
Kingdom. They suggest similar outcomes to single vessel
CABG or OPCAB through standard sternotomy, endo-
ACAB as well as percutaneous coronary interventions
and similar practices of robotically enhanced coronary
procedures elsewhere in the world.
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